Maria Kamusheva

The European challenges of funding orphan medicinal products

Márta Szegedi, Tamás Zelei, Francis Arickx et al. · Orphanet Journal of Rare Diseases · 2018 · 63 citations · Full text

Public Affairs, Health Policy, Pharmaceutical Policy +17

Assessment of the expectancy, seriousness and severity of adverse drug reactions reported for chronic obstructive pulmonary disease therapy

Guenka Petrova, Maria Dimitrova, Maria Kamusheva et al. · SAGE Open Medicine · 2017 · 58 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Barriers to Use Artificial Intelligence Methodologies in Health Technology Assessment in Central and East European Countries

Konstantin Tachkov, Antal Zemplényi, Maria Kamusheva et al. · Frontiers in Public Health · 2022 · 49 citations · Full text

Public Affairs, Health Informatics, Health Policy +13

Proposal for a regulation on health technology assessment in Europe – opinions of policy makers, payers and academics from the field of HTA

Patricia Vella Bonanno, Anna Bucsics, Steven Simoens et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 2019 · 46 citations · Full text

Social Sciences, Health Law, Health Policy +13

Life expectancy and survival analysis of patients with diabetes compared to the non diabetic population in Bulgaria

Konstantin Tachkov, Konstantin Mitov, Yordanka N. Koleva et al. · PLoS ONE · 2020 · 41 citations · Full text

Social Sciences, Biostatistics, Internal Medicine +17